欢迎来到天天文库
浏览记录
ID:55273942
大小:247.41 KB
页数:3页
时间:2020-05-12
《灯盏细辛注射液对ARDS炎性因子及凝血机制的影响.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、——854——中国中医急症2015年5月第24卷第5期JETCM.May2015,Vo1.24,No.5灯盏细辛注射液对ARDS炎性因子及凝血机制的影响;l:郭献阳陈如杰庄荣(温州医科大学附属第二医院,浙江温州325027)中图分类号:R563.8文献标志码:A文章编号:1004—745X(2015)05—0854—03doi:10.3969/j.issn.1004-745X.2015.05.036【摘要】目的观察灯盏细辛注射液对中一重度急性呼吸窘迫综合征(ARDS)患者炎症因子及凝血功能的影响,并评价其临床效
2、果。方法30例患者随机分成对照组和灯盏细辛组。两组均给予常规治疗,灯盏细辛组在常规治疗基础上每天加用灯盏细辛注射液30mL静脉滴注.共15d。测定两组患者治疗前后C反应蛋白(CRP)、肿瘤坏死因子~{x(TNF一仅)、白介素一6(IL一6)及纤维蛋白原(FIB)、纤溶酶原活性(PLG)、假性血友病因子(vWF),观察氧和指数(PaOJFiO:),SOFA评分的变化,观察机械通气时间、住ICU时间、住院时间及28d死亡率。结果与对照组比较,灯盏细辛组治疗后15dCRP水平下降(P<0.05),FIB下降(P<0.
3、01),vWF下降(P<0.05),PLG升高(P4、-tientsGUOXianyang,CHENRujie,ZHUANGRong.TheSecondAffiliatedHospitd,WenzhouMedicalUni—versity,Zhejiang,Wenzhou325027,China【Abstract】Objective:ToobservetheeffectoferigeronbreviscapusinjectionOUinflammatoryreactionandbloodclottinginpatientswithacuterespiratoryd5、istresssyndrome(ARDS)andevaluateitsclinicalresult.Methods:30ARDSpatientswererandomlydividedintothecontrolgroup(groupC)andtheerigeronbreviscapusinjectiongroup(groupE).GroupEreceiveerigeronbreviscapusinjection30mLdailyfor15daysonthebasisofroutinetherapiesin2gr6、oups.Changespriortreatmentandupto15daywillberecordedincludingC-reactiveprotein(CRP),TNF—,IL一6,fibrinogen(FIB),plasminogen(PLG),vonWillebrand(vWF),oxygenationindex(Pa02/Fi02)andsequentialorganfailureassessmentscore(SOFA).Also,someindicatorswereobservedsuchast7、hemechani.ca1ventilationtime,thelengthofICU,thehospitalstayandthe28daystimemortality.Results:ComparedwithgroupC,theCRP,theTNF-ct,theIL-6,FibandvWFweredecreased(P<0.05orP<0.01).PLGwasincreased(P<0.05).SOFAscorewasdecreased(P<0.05)andOxygenationindexwasincreas8、ed(P<0.05)inGroupEupto15days.Meanwhile,theMechanicalventilationtimeandtheICUandhospitalstaytimewerereduced(P<0.05).However,therewasnosignificantdifferenceinmortalitybetweenthetwogroups.Conclusio
4、-tientsGUOXianyang,CHENRujie,ZHUANGRong.TheSecondAffiliatedHospitd,WenzhouMedicalUni—versity,Zhejiang,Wenzhou325027,China【Abstract】Objective:ToobservetheeffectoferigeronbreviscapusinjectionOUinflammatoryreactionandbloodclottinginpatientswithacuterespiratoryd
5、istresssyndrome(ARDS)andevaluateitsclinicalresult.Methods:30ARDSpatientswererandomlydividedintothecontrolgroup(groupC)andtheerigeronbreviscapusinjectiongroup(groupE).GroupEreceiveerigeronbreviscapusinjection30mLdailyfor15daysonthebasisofroutinetherapiesin2gr
6、oups.Changespriortreatmentandupto15daywillberecordedincludingC-reactiveprotein(CRP),TNF—,IL一6,fibrinogen(FIB),plasminogen(PLG),vonWillebrand(vWF),oxygenationindex(Pa02/Fi02)andsequentialorganfailureassessmentscore(SOFA).Also,someindicatorswereobservedsuchast
7、hemechani.ca1ventilationtime,thelengthofICU,thehospitalstayandthe28daystimemortality.Results:ComparedwithgroupC,theCRP,theTNF-ct,theIL-6,FibandvWFweredecreased(P<0.05orP<0.01).PLGwasincreased(P<0.05).SOFAscorewasdecreased(P<0.05)andOxygenationindexwasincreas
8、ed(P<0.05)inGroupEupto15days.Meanwhile,theMechanicalventilationtimeandtheICUandhospitalstaytimewerereduced(P<0.05).However,therewasnosignificantdifferenceinmortalitybetweenthetwogroups.Conclusio
此文档下载收益归作者所有